Priority Date: 30.12.11 (EP 20110196215)

SECOND GENERATION VIRUS-LIKE PARTICLES (VLP) FROM EPSTEIN-BARR VIRUSES FOR VACCINATION PURPOSES

  • Application ID: EP12813047
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorney

operating since 2010
Headquarter in Munich and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 30.12.2011 - Priority Date (EP 20110196215)
  • 04.07.2013 - Publication A1 (WO2013098364)
  • 05.11.2014 - Publication A1 (EP2797626)

IPC Classification